Quick Answer
Insight Molecular Diagnostics Inc. reported Net Income of -$50.22 million for fiscal year 2025.
Insight Molecular Diagnostics Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$50.22M | +17.2% |
| 2024 | -$60.66M | -118.4% |
| 2023 | -$27.78M | +61.9% |
| 2022 | -$72.90M | -13.7% |
| 2021 | -$64.10M | -114.1% |
| 2020 | -$29.93M | -33.5% |
| 2019 | -$22.43M | -42.4% |
| 2018 | -$15.75M | +18.7% |
| 2017 | -$19.38M | -73.5% |
| 2016 | -$11.17M | -27.9% |
| 2015 | -$8.73M | -75.2% |
| 2014 | -$4.99M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.85M | +19.6% | -11.4% |
| June 30, 2025 | -$9.74M | -115.1% | -46.0% |
| March 31, 2025 | -$6.67M | +26.9% | +50.6% |
| September 30, 2024 | -$13.49M | -107.9% | -197.9% |
| June 30, 2024 | -$4.53M | +45.6% | +50.4% |
| March 31, 2024 | -$9.13M | -401.0% | -40.7% |
| September 30, 2023 | -$6.49M | +30.5% | +22.1% |
| June 30, 2023 | -$8.33M | -0.4% | -374.7% |
- Insight Molecular Diagnostics Inc. showed an increase of +17.2% in Net Income compared to the prior fiscal year.
- Over the 2014–2025 period, Insight Molecular Diagnostics Inc.’s net income has declined by 907.3% (from -$4.99 million to -$50.22 million).
- The most recent figure is from Insight Molecular Diagnostics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: